These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21183302)

  • 1. Vascular patterns in nodules of intraductal papillary mucinous neoplasms depicted under contrast-enhanced ultrasonography are helpful for evaluating malignant potential.
    Kurihara N; Kawamoto H; Kobayashi Y; Okamoto Y; Yamamoto N; Tsutsumi K; Fujii M; Kato H; Yamamoto K
    Eur J Radiol; 2012 Jan; 81(1):66-70. PubMed ID: 21183302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas.
    Itoh T; Hirooka Y; Itoh A; Hashimoto S; Kawashima H; Hara K; Kanamori A; Ohmiya N; Niwa Y; Goto H
    Am J Gastroenterol; 2005 Jan; 100(1):144-52. PubMed ID: 15654794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
    Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
    Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
    Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
    Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
    Zhang J; Wang PJ; Yuan XD
    Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging.
    Sofuni A; Iijima H; Moriyasu F; Nakayama D; Shimizu M; Nakamura K; Itokawa F; Itoi T
    J Gastroenterol; 2005 May; 40(5):518-25. PubMed ID: 15942718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions.
    Fujita M; Itoi T; Ikeuchi N; Sofuni A; Tsuchiya T; Ishii K; Kamada K; Umeda J; Tanaka R; Tonozuka R; Honjo M; Mukai S; Moriyasu F
    Endosc Ultrasound; 2016; 5(6):377-383. PubMed ID: 28000629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
    Vullierme MP; Giraud-Cohen M; Hammel P; Sauvanet A; Couvelard A; O'Toole D; Levy P; Ruszniewski P; Vilgrain V
    Radiology; 2007 Nov; 245(2):483-90. PubMed ID: 17848678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study.
    Yamashita Y; Ueda K; Itonaga M; Yoshida T; Maeda H; Maekita T; Iguchi M; Tamai H; Ichinose M; Kato J
    J Ultrasound Med; 2013 Jan; 32(1):61-8. PubMed ID: 23269711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
    Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
    Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
    D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
    Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Contrast-Enhanced Harmonic Endoscopic Ultrasonography for Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasm.
    Yamashita Y; Kawaji Y; Shimokawa T; Yamazaki H; Tamura T; Hatamaru K; Itonaga M; Ashida R; Kawai M; Kitano M
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers.
    Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Hosoda W; Nakamura Y; Shinohara T; Yanagisawa A
    Pancreas; 2013 Jul; 42(5):883-8. PubMed ID: 23508017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms with associated invasive carcinoma of the pancreas: imaging findings and diagnostic performance of MDCT for prediction of prognostic factors.
    Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
    AJR Am J Roentgenol; 2013 Sep; 201(3):565-72. PubMed ID: 23971447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes.
    Gupta R; Mortelé KJ; Tatli S; Girshman J; Glickman JN; Levy AD; Erturk SM; Heffess CS; Banks PA; Silverman SG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1458-64. PubMed ID: 18941085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.